Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found. from NDTV News - Topstories https://ift.tt/3nX8fwP via IFTTT
ResultBro - Think Exam Results and be inspired by ResultBro